Welcome to the UPF Digital Repository

Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases



Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases

Thumbnail
Document Type: Article
Version: Published version
Date: 2023
This document is associated with a Creative Common license © 2023 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology. This is an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Thumbnail

This item appears in the following Collection(s)

Search DSpace


Advanced Search

Browse

My Account

Statistics

In collaboration with Compliant to Partaking